Method and use
US6573291B2 · kind B2 · utility
19Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2001 |
| Grant date | Jun 3, 2003 |
| Priority date | — |
| Expiry date | Dec 3, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D231/16
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to a method of antagonizing GLP-1 activity in a mammalian patient, comprising administering to said patient an effective amount of a compound of the general formula I: whereinR1 and R2 independently of each other are C1-4alkyl,R3 is halogen, hydroxy, C1-4-alkoxy or trifluoromethoxy,R4 is hydrogen, hydroxy or C1-4-alkoxy,or a pharmacologically acceptable salt thereof. The invention also relates to a pharmaceutical composition comprising a compound of formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.